Movement disorders secondary to central nervous system disease and skeletal-muscle overactivity can be extremely debilitating.
Chronic use of certain drugs can cause this rheumatologic syndrome
Despite the availability of effective antiretroviral therapy, more
than 25% of people with HIV infection will develop neurologic
disorders.
Therapeutic benefits of this compound include efficacy against Alzheimer’s disease and various cancers.
New methods for treating this common nosocomial infection are being implemented.
Underlying conditions and comorbidities make it difficult to properly manage this disorder.
The pharmacy technician’s role is evolving and varies widely between the
retail industry and hospital health systems, as well as from state to
state.
Pharmacists and other medical practitioners should carefully weigh the risks and benefits of this treatment approach, which has roots dating back centuries.
Patients generally present with major depression and at least one hypomanic episode.
Antidepressants can help treat prolonged depressed mood and anhedonia.
New molecular entities, as defined by the FDA, are new drug
products containing as their active ingredient a chemical substance
marketed for the first time in the United States.
Novel agents are being investigated to achieve a better therapeutic outcome and a reduction in adverse events.
Only true computer-to-computer electronic data interchange using a nationally accepted standard is defined as genuine e-prescribing.
For years, chronic obstructive pulmonary disease prevalence in the United States was higher in men than
in women; however, a shift in the gender paradigm has occurred within
the last three decades.
This assay helps determine whether trastuzumab treatment may be considered.
For more articles, please check our archives.